HER2 Dual ISH test to assess eligibility for Trastuzumab (Herceptin) in breast cancer patients receiving treatment from public hospitals

View Statistics Email Alert RSS Feed

Grant Data
Project Title
HER2 Dual ISH test to assess eligibility for Trastuzumab (Herceptin) in breast cancer patients receiving treatment from public hospitals
Principal Investigator
Professor Khoo, Ui Soon   (Principal Investigator (PI))
Co-Investigator(s)
Dr Yeung Mei Wan Rebecca   (Co-Investigator)
Dr Leung To Wai   (Co-Investigator)
Dr Soong Inda   (Co-Investigator)
Dr Luk Mai Yee   (Co-Investigator)
Duration
12
Start Date
2013-11-01
Amount
319640
Conference Title
HER2 Dual ISH test to assess eligibility for Trastuzumab (Herceptin) in breast cancer patients receiving treatment from public hospitals
Presentation Title
Keywords
breast, cancer, Dual, HER2, Herceptin, Trastuzumab
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
213218
Grant Type
S.K. Yee Medical Foundation - General Award
Funding Year
2013
Status
On-going